Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA

Authors Information
Article Notes and Dates
To Cite : Sosa-Jurado F, Hilda Rosas-Murrieta N, Guzman-Flores B, Perez Zempoaltecalt C, Patricia Sanchez Torres A, et al. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA, Hepat Mon. 2016 ;16(6):e36942. doi: 10.5812/hepatmon.36942.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD. Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med. 2008; 75(12): 881-9[DOI][PubMed]
  • 2. de la Fuente RA, Gutierrez ML, Garcia-Samaniego J, Fernandez-Rodriguez C, Lledo JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol. 2011; 17(12): 1543-8[DOI][PubMed]
  • 3. Larrubia JR. Occult hepatitis B virus infection: a complex entity with relevant clinical implications. World J Gastroenterol. 2011; 17(12): 1529-30[DOI][PubMed]
  • 4. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Sepúlveda J. Prevalencia en México de la infección y el estado de portador de la hepatitis B en adultos. Salud Pública de México. 2007; 49-11[DOI]
  • 5. Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, et al. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol. 2010; 82(9): 1527-36[DOI][PubMed]
  • 6. Garcia-Montalvo BM, Farfan-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005; 15(5): 371-8[DOI][PubMed]
  • 7. Garcia-Montalvo BM, Ventura-Zapata LP. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Ann Hepatol. 2011; 10(2): 133-41[PubMed]
  • 8. Gish RG, Lau JY, Brooks L, Fang JW, Steady SL, Imperial JC, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology. 1996; 23(1): 1-7[DOI][PubMed]
  • 9. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4): 406-25[PubMed]
  • 10. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011; 28(10): 2731-9[DOI][PubMed]
  • 11. Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014; 20(24): 7653-64[DOI][PubMed]
  • 12. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol. 2012; 57(4): 720-9[DOI][PubMed]
  • 13. ARCHITECT HBsAg Qualitative, REF 1P97, 48-582/R2, B1P970. Technical manual. 2009;
  • 14. La'ulu SL, Roberts WL. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol. 2006; 125(5): 748-51[DOI][PubMed]
  • 15. Chiquete E, Sanchez LV, Becerra G, Quintero A, Maldonado M, Panduro A. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center. Ann Hepatol. 2005; 4(4): 275-8[PubMed]
  • 16. Monteon VM, Reyes-Lopez PA, Sosa-Palacio A, Leon-Tello G, Martinez-Murguia J, Sosa-Jurado F. [Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the State of Puebla, Mexico]. Salud Publica Mex. 2005; 47(2): 116-25[PubMed]
  • 17. Garcia-Montalvo BM. [Seropositivity of HIV, HBV, HCV and Treponema pallidum in blood donors in southeast Mexico]. Rev Invest Clin. 2006; 58(6): 567-72[PubMed]
  • 18. Rojas-Garcia Mde J, Aguilar-Tlapale R, Montalvo-Melo MC, Sanchez- Aleman MA, Hernandez-Giron C. [Seroprevalence of sexually transmitted infections in blood donors from the state blood transfusion center, Tlaxcala, Mexico]. Salud Publica Mex. 2008; 50(6): 437-8[PubMed]
  • 19. Valerio-Urena J, Vasquez-Fernandez F, Perez-Sosa JA, Cortazar-Benitez LF, Chavez-Tapia NC, Ruvalcaba-Rojas OA, et al. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico]. Gac Med Mex. 2009; 145(3): 183-7[PubMed]
  • 20. Serrano Machuca JJ, Villarreal Rios E, Galicia Rodriguez L, Vargas Daza ER, Martinez Gonzalez L, Mejia Damian AF. [Detection of antibodies present in blood donors in Mexico]. Rev Panam Salud Publica. 2009; 26(4): 355-9[PubMed]
  • 21. Juarez-Figueroa LA, Uribe-Salas FJ, Conde-Gonzalez CJ. Heterogeneous distribution of hepatitis B serological markers in rural areas of Mexico. Salud Publica Mex. 2011; 53 Suppl 1-31[PubMed]
  • 22. Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol. 2015; 7(3): 600-6[DOI][PubMed]
  • 23. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 24. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol. 2007; 13(43): 5682-6[PubMed]
  • 25. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012; 25(1): 142-63[DOI][PubMed]
  • 26. Gerlich WH. Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. Intervirology. 2004; 47(6): 310-3[PubMed]
  • 27. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion. 2007; 47(7): 1162-71[DOI][PubMed]
  • 28. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, et al. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion. 2007; 47(10): 1809-15[DOI][PubMed]
  • 29. Said ZN, Sayed MH, Salama ,I, Aboel-Magd EK, Mahmoud MH, Setouhy ME, et al. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013; 5(2): 64-73[DOI][PubMed]
  • 30. Allain JP, Cox L. Challenges in hepatitis B detection among blood donors. Curr Opin Hematol. 2011; 18(6): 461-6[DOI][PubMed]
  • 31. Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion. 2012; 52(2): 440-6[DOI][PubMed]
  • 32. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NG. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Transfusion. 2014; 54(8): 2084-91[DOI][PubMed]
  • 33. Alvarado-Esquivel C, Sablon E, Conde-Gonzalez CJ, Juarez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S. Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H. World J Gastroenterol. 2006; 12(40): 6540-5[PubMed]
  • 34. Ruiz-Tachiquin ME, Valdez-Salazar HA, Juarez-Barreto V, Dehesa-Violante M, Torres J, Munoz-Hernandez O, et al. Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers. Virol J. 2007; 4: 6[DOI][PubMed]
  • 35. Roman S, Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez-Vandyck M, Martinez-Lopez E, et al. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int. 2009; 3(2): 343-55[DOI][PubMed]
  • 36. Cruz JR, Perez-Rosales MD. Availability, safety, and quality of blood for transfusion in the Americas. Rev Panam Salud Publica. 2003; 13(2-3): 103-10[PubMed]
  • 37. General health information management, Epidemiological and Statistical deaths Subsystem (SEED). General deaths (INEGI / HEALTH). 2015;
  • 38. Zhang M, Wu R, Jiang J, Minuk GY, Niu J. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis. Alcohol. 2013; 47(7): 553-8[DOI][PubMed]
  • 39. Xie M, Rao W, Yang T, Deng Y, Zheng H, Pan C, et al. Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation. Liver Int. 2015; 35(3): 897-904[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check